4757
-
Neuropsychiatric Disease and Treatment
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Neuropsychiatric Disease and Treatment
(1,264,213) Views
Editor in Chief Dr Roger M Pinder
1176-6328
Role of pregabalin in the treatment of generalized anxiety disorderDavid S Baldwin, Khalil Ajel
Clinical variables and implications of the personality on the outcome of bipolar illness: a pilot study
Nieves Casas-Barquero, Olga García-López, Pedro Fernández-Argüelles, Manuel Camacho-Laraña
Editorial: Treatment of generalized anxiety disorder || FREE PAPER ||
Roger M Pinder
Duloxetine in the treatment of major depressive disorder
David J Goldstein
Rivastigmine in the treatment of patients with Alzheimer’s disease
Thomas Müller
An alternative approach to measuring treatment persistence with antipsychotic agents among patients with schizophrenia in the Veterans Health Administration
Xinhua S Ren, Shirley Qian, Lewis E Kazis
Quetiapine in the treatment of schizophrenia
Michael Riedel, Norbert Müller, Martin Strassnig, Ilja Spellmann, Emanuel Severus, Hans-Jürgen Möller
The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic
Jeffrey R Strawn, Thomas D Geracioti Jr
Glatiramer acetate in the treatment of multiple sclerosis
Alex Tselis, Omar Khan, Robert P Lisak
Memantine: efficacy and safety in mild-to-severe Alzheimer’s disease
Rajesh R Tampi, Christopher H van Dyck
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
